Making Medicines Safer (2018)

Since its birth in 1978, UMC has supported the WHO Programme for International Drug Monitoring, which was established to collect information about adverse effects of medicines. Gathering data from as many sources as possible across the world ensured that the first signs of possible danger from medicines would not be missed. Four decades later, with our team of over 100 dedicated and passionate staff, UMC continues to work closely with colleagues in WHO Headquarters in Geneva to support and promote patient safety through effective and global pharmacovigilance practice.